SANUWAVE HEALTH, INC. Financials SANUWAVE Health, Inc.
Equities
SNWV
US80303D1072
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.022 USD | +5.26% |
|
-3.93% | +69.23% |
| May. 10 | Transcript : SANUWAVE Health, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
| May. 09 | SANUWAVE Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 35.77 | 43.03 | 86.43 | 81.88 | 12.51 | 14.83 |
| Enterprise Value (EV) 1 | 46.3 | 48.21 | 101.6 | 109.2 | 52.46 | 44.97 |
| P/E ratio | -2.96 x | -3.12 x | -2.81 x | -3.23 x | -1.14 x | -0.4 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 19.3 x | 41.8 x | 21.3 x | 6.29 x | 0.75 x | 0.73 x |
| EV / Revenue | 25 x | 46.9 x | 25 x | 8.39 x | 3.13 x | 2.2 x |
| EV / EBITDA | -6.47 x | -5.53 x | -6.4 x | -8.46 x | -6.56 x | 92.2 x |
| EV / FCF | -128 x | -8.36 x | 287 x | 42.7 x | -2.77 x | 4.84 x |
| FCF Yield | -0.78% | -12% | 0.35% | 2.34% | -36.1% | 20.7% |
| Price to Book | -2.33 x | -4.67 x | -6.35 x | -2.1 x | -0.31 x | -0.34 x |
| Nbr of stocks (in thousands) | 155,533 | 268,907 | 467,195 | 481,620 | 548,738 | 1,140,560 |
| Reference price 2 | 0.2300 | 0.1600 | 0.1850 | 0.1700 | 0.0228 | 0.0130 |
| Announcement Date | 4/1/19 | 3/30/20 | 10/21/21 | 5/13/22 | 3/31/23 | 3/21/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.85 | 1.029 | 4.057 | 13.01 | 16.74 | 20.4 |
| EBITDA 1 | -7.158 | -8.723 | -15.87 | -12.91 | -8 | 0.488 |
| EBIT 1 | -7.18 | -8.794 | -16.88 | -14.14 | -8.952 | -0.54 |
| Operating Margin | -388.11% | -854.87% | -416.02% | -108.7% | -53.47% | -2.65% |
| Earnings before Tax (EBT) 1 | -11.63 | -10.43 | -30.94 | -27.23 | -10.29 | -25.8 |
| Net income 1 | -11.63 | -10.43 | -30.94 | -27.26 | -10.29 | -25.81 |
| Net margin | -628.7% | -1,013.86% | -762.47% | -209.52% | -61.48% | -126.52% |
| EPS 2 | -0.0778 | -0.0512 | -0.0657 | -0.0526 | -0.0200 | -0.0325 |
| Free Cash Flow 1 | -0.361 | -5.767 | 0.3542 | 2.557 | -18.94 | 9.297 |
| FCF margin | -19.52% | -560.64% | 8.73% | 19.65% | -113.15% | 45.58% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 1,905.15% |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/1/19 | 3/30/20 | 10/21/21 | 5/13/22 | 3/31/23 | 3/21/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 10.5 | 5.18 | 15.2 | 27.3 | 40 | 30.1 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -1.471 x | -0.594 x | -0.9556 x | -2.117 x | -4.994 x | 61.78 x |
| Free Cash Flow 1 | -0.36 | -5.77 | 0.35 | 2.56 | -18.9 | 9.3 |
| ROE (net income / shareholders' equity) | 92.2% | 82.1% | 260% | 103% | 25.7% | 61.3% |
| ROA (Net income/ Total Assets) | -365% | -241% | -79.9% | -42.4% | -29.1% | -1.6% |
| Assets 1 | 3.184 | 4.326 | 38.72 | 64.22 | 35.41 | 1,617 |
| Book Value Per Share 2 | -0.1000 | -0.0300 | -0.0300 | -0.0800 | -0.0700 | -0.0400 |
| Cash Flow per Share 2 | 0 | 0.0100 | 0.0100 | 0 | 0 | 0 |
| Capex 1 | 0.04 | 0.05 | 0.05 | 0.53 | - | - |
| Capex / Sales | 2.32% | 5.24% | 1.3% | 4.07% | - | - |
| Announcement Date | 4/1/19 | 3/30/20 | 10/21/21 | 5/13/22 | 3/31/23 | 3/21/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +69.23% | 23.95M | |
| -5.39% | 182B | |
| +3.88% | 114B | |
| -3.36% | 68.38B | |
| +6.05% | 52.46B | |
| +8.09% | 44.25B | |
| +7.52% | 43.55B | |
| +25.07% | 32.69B | |
| +17.85% | 26.73B | |
| -0.75% | 25.79B |
- Stock Market
- Equities
- SNWV Stock
- Financials SANUWAVE Health, Inc.